Back to BAMCO Inc. BAMCO Inc.

ARWR

21 quarters

Position history for BAMCO Inc.BAMCO Inc.'s holdings in Arrowhead Pharmaceuticals, Inc.

No. BAMCO exited its ARWR (Arrowhead Pharmaceuticals) position in Q4 2023. Its Q3 2023 13F listed 156,619 shares worth $4.2M. BAMCO already held ARWR in its Q4 2018 13F, the earliest on record, and held it in 20 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$2.1M

Total Shares Change

-166,847

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2023-Q4
Latest
Exited
0
-100.0%
$00.0%$30.60
0
2023-Q3
Increased
156,619
+0.1%
$4.2M0.0%$26.87
27
2023-Q2
Increased
156,445
+19.1%
$5.6M0.0%$35.66
32
2023-Q1
Decreased
131,318
-17.5%
$3.3M0.0%$25.40
0
2022-Q4
Decreased
159,175
-53.0%
$6.5M0.0%$40.56
0
2022-Q3
Decreased
338,792
-0.0%
$11.2M0.0%$33.05
0
2022-Q2
Decreased
338,942
-62.0%
$11.9M0.0%$35.21
0
2022-Q1
Decreased
891,241
-10.1%
$41M0.1%$45.99
0
2021-Q4
Decreased
991,393
-1.6%
$65.7M0.1%$66.30
0
2021-Q3
Decreased
1M
-0.6%
$62.9M0.1%$62.43
0
2021-Q2
Increased
1M
+9.6%
$83.9M0.2%$82.82
39
2021-Q1
Increased
924,430
+39.1%
$61.3M0.2%$66.31
47
2020-Q4
Increased
664,637
+78.9%
$51M0.1%$76.73
54
2020-Q3
Increased
371,421
+42.5%
$16M0.0%$43.06
38
2020-Q2
Increased
260,709
+136.5%
$11.3M0.0%$43.19
45
2020-Q1
Increased
110,250
+40.3%
$3.2M0.0%$28.77
35
2019-Q4
Decreased
78,594
-52.7%
$5M0.0%$63.43
0
2019-Q3
Increased
166,294
+0.3%
$4.7M0.0%$28.18
27
2019-Q2
Decreased
165,794
-1.0%
$4.4M0.0%$26.50
0
2019-Q1
Increased
167,494
+0.4%
$3.1M0.0%$18.35
26
2018-Q4
First report
166,847
-
$2.1M0.0%$12.42
0

Other major holders of ARWR: BlackRock, Inc., Vanguard Group Inc., Avoro Capital Advisors LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used